期刊文献+

系统性红斑狼疮早发动脉粥样硬化机制的研究进展 被引量:2

Mechanisms of Premature Atherosclerosis in Systemic Lupus Erythematosus
下载PDF
导出
摘要 系统性红斑狼疮(systemic lupus erythematosus,SLE)是一种累及多系统多器官的自身免疫性疾病。近年来,随着临床诊治水平的显著提高,患者预后得到明显改善,远期死亡(诊断5年后)原因得到关注。作为SLE远期主要并发症的早发动脉粥粥样硬化,成为近年研究的热点。该文对SLE中早发动脉粥样硬化发病机制的研究进展进行综述。 ystemic lupus erythematosus is an autoimmune disease which may affect nearly every organ. In recently years ,with the progress of clinical treatment, SLE prognosis has been greatly enhanced, and the causes of late death ( 5 years after diagnosis) are drawing increasing attention. As a major complication, atherosclerosis has become a hotspot in recent academic community. This review will focus on the recent advances on the mechanisms of premature atherosclerosis in SLE.
作者 常文静 蔡辉
出处 《安徽医药》 CAS 2014年第9期1617-1621,共5页 Anhui Medical and Pharmaceutical Journal
关键词 系统性红斑狼疮 动脉粥样硬化 心血管疾病 systemic lupus erythematosus atherosclerosis cardiovascular disease
  • 相关文献

参考文献28

  • 1Manzi S, Meilahn EN , Rairie JE , et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study [J] . Am J Epidemiol,1997 ,145(5) :408 -415.
  • 2Roman MJ, Crow MK, Lockshin MD, et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus [J] . Arthritis Rheum,2007 ,56(10) :3412 -3419.
  • 3Manzi S,Selzer F .Sutton-Tyrrell K,et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus [J] . Arthritis Rheum, 1999,42(1 ) :51 - 60.
  • 4Kiani AN, Vogel-Claussen J, Magder LS, et al. Noncalcified coronary plaque in systemic lupus erythematosus [J] . J Rheumatol, 2010,37 (3) :579 - 584.
  • 5Recio-Mayoral A, Mason JC,Kask1] C,et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease [J] . E ur Heart 1, 2009 ,30 (I5) : 1837 -1843.
  • 6Gustafsson JT , Simard JF , Gunnarsson I, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study [J] . Arthritis Res Ther , 2012, 14 (2) :R46.
  • 7Mc Mahon M, Grossman J, Skaggs B, et al. Dysfunctional proinflammatory high -density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus [J] . Arthri- tis Rheum,2009,60(8) :2428 -2437.
  • 8l.ood C, Amisten S, Gullstrand B, et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up- regulation of the type I interferon system is strongly associated with vascular disease[J] . Blood ,2010, 116( 11) : 1951 -1957.
  • 9Thacker SG, Zhao W , Smith CK, et al. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis [J] . Arthritis Rheum, 2012,64(9) :2975 -2985.
  • 10Westerweel PE, Luijten RK, Hoefer IE, et al. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus [J] . Ann Rheum Dis, 2007 ,66 (7) : 865 - 870.

同被引文献46

  • 1Sarkissian T, Beyenne J, Feldman B , et al. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus[ J]. Arthrities Rheum,2006,54 (4) : 1283 - 1290.
  • 2Ettinger WH, Goldberg AP, Applebaum Bowden D, et al. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids[ J]. Am J Med,1987,83(3) :503 -508.
  • 3Svens0n KL, Lundqvist G, Wide L, et al. Impaired glucose handling in active rheumatoid arthritis, effects of corticosteroids and antirheumatic treatment [J ]. Metabolism, 1987,36 ( 10 ) - 944 - 948.
  • 4Petri M. Detection of coronary artery disease and the role of tradi- tional risk factors in the Hopkins Lupus Cohort [ J ] Lupus,2000,9 (3) :170 - 175.
  • 5Bazzan M, Vaccarino A, Marletto F. Systemic lupus erythematosus and thrombosis[ J]. Thromb J ,2015,13 : 16.
  • 6Skaggs B J, Hahn BH, McMahon M. Accelerated atherosclerosis in patients with SLE - mechanisms and management [ J ]. Nat Rev Rheumatol,2012,8 (4) : 214 - 223.
  • 7Pego - Reigosa JM, Rua - Figueroa l, Lopez - Longo FJ, et al. Analysis ,of disease activity and response to treatment in a largeSpanish cohort of patients with systemic lupus erythematosus[ J ]. Lupus,2015,24 (7) :720 - 729.
  • 8Sinieato NA, da Silva Cardoso PA, Appenzeller S. Risk factors in cardiovascular disease in systemic lupus erythematosus [ J ]. Curr Cardiol Rev,2013,9( 1 ) :15 -19.
  • 9PanaroUn D, Remillard P, Rouffard L, et al. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue speeitfic manner [J]. Eur J Clin Invest, 2002,32(2) :84 -92.
  • 10Gazareen S, Fayez D, El - Najjar M, et al. Study of insulin resist- ance in patients with systemic lupus erythematosus and rheumatoid arthritis [ J ]. Menoufia Medical Journal,2014,27 ( 2 ) :215 - 225.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部